VERA
Vera Therapeutics, Inc. Class A Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:59 PM EDT
30.42USD-1.855%(-0.57)1,614,860
After-hoursOct 2, 2026 4:26:30 PM EDT
30.42USD+0.016%(+0.00)
Loading…
Loading…
2.19B
Healthcare
Biotechnology
HQ
Brisbane, CA, USA
Previous Close
$30.99
Beta
1.20
52-Week High
$56.05 2025-12-24
52-Week Low
$23.05 2025-11-06
SMA 50
$33.08
SMA 200
$39.02
Avg. Vol 10D
1.55M
Avg. Vol 30D
2.33M
Avg. Vol 90D
2.13M
Relative Vol
0.69
72.06M
58.51M
81.20%
17,035,040
29.11%
6.18
54%/46%
56.12%
45.86%
0.3400%
1,100,000
14
509
Nov 4, 2026 (30d)
Oct 2, 2026
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · 
GlobeNewswire Inc.
Sep 15, 2026
Noteworthy Tuesday Option Activity: AVGO, VERA, QCOM · 
BNK Invest
VERA Profile
trucode gene repair is advancing its novel triplex gene editing platform to potentially cure devastating genetic diseases, with initial focus on sickle cell disease and cystic fibrosis. the elegance of triplex gene editing lies in its ability to harness natural, high-fidelity dna repair mechanisms, and its independence from the requirement for exogenous nucleases and viral vectors.
VERA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 32.50 | 2026-09-28 | -6.35% | -1.869 |
| 1M | 35.89 | 2026-09-04 | -15.19% | 3.067 |
| 3M | 40.13 | 2026-07-06 | -24.15% | 0.527 |
| 6M | 40.45 | 2026-04-06 | -24.74% | 0.772 |
| 1Y | 30.94 | 2025-10-06 | -1.62% | 1.196 |
| 2Y | 40.84 | 2024-10-04 | -25.47% | — |
| 5Y | 15.43 | 2021-10-05 | +97.26% | 1.047 |
VERA Stock Summary
Vera Therapeutics, Inc. Class A Common Stock (NASDAQ:VERA) stock price today is $30.44, and today's volume is 1,614,860. VERA is down 1.783% today. The 30 day average volume is 2.33M. VERA market cap is $2.19B with 72.06M shares outstanding.